In addition to a potentially effective treatment for humans with HIV, the combination also shows potential to treat cats with leukemia.
A University of Minnesota research team featuring researchers from the Institute for Molecular Virology, School of Dentistry and Center for Drug Design has developed a new delivery system for a combination of two FDA approved drugs that may serve as an effective treatment for the human immunodeficiency virus (HIV).
The discovery, which allows for a combination of decitabine and gemcitabine to be delivered in pill form, marks a major step forward in patient feasibility for the drugs, which previously had been available solely via injection or intravenous therapy (IV).
The study, coauthored by Christine Clouser, Ph.D., Laurent Bonnac, Ph.D., Louis Mansky, Ph.D., and Steven Patterson, Ph.D., can be found “online first” in the journal Antiviral Chemistry & Chemotherapy.
“If you have a condition that requires you to take a medication everyday, as many patients with HIV do, you wouldn’t want to have to take that medication via daily injection,” said Steven Patterson, Ph.D., professor at the Center for Drug Design at the University of Minnesota. “This finding is a big step in demonstrating this treatment could be taken as a pill, similar to other HIV drugs, and is suitable for eventual clinical translation.”
University of Minnesota researchers first announced decitabine and gemcitabine could potentially combine to treat HIV in research published in August 2010. The drug combination was shown to work by lethal mutagenesis that could obliterate HIV by causing the virus to mutate to a point where it was no longer infectious. For some patients, HIV’s ability to quickly mutate and evolve can result in drug resistance. For patients who have developed resistance to currently available HIV treatments, the decitabine-gemcitabine drug combination could prove an effective alternative and secondary line of defense.
In addition to a potentially effective treatment for humans with HIV, the combination also shows potential to treat cats with leukemia.
The Latest Bing News on:
Decitabine and gemcitabine
- Cisplatin Plus Gemcitabine as Adjuvant Chemotherapy for Radically Resected Non–Small-cell Lung Cancer: A Pilot Studyon March 26, 2024 at 5:00 pm
The chemotherapy regimen consisted of cisplatin 80 mg/m 2 on day 1 and gemcitabine (1200 mg/m 2 in 250 mL of normal saline) administered by I.V. over 30 minutes on days 1 and 8 every 3 weeks for a ...
- What Is Decitabine And Common Side Effectson March 21, 2024 at 2:28 pm
SHPART target=_blank>injection.This abstract examines the use of Decitabine, a drug used to treat acute myeloid leukaemia (AML) and myelodysplastic syndrome (MDS). It outlines the brand names, ...
- Researchers pinpoint issue that could be hampering common chemotherapy drugon March 17, 2024 at 5:00 pm
Researchers at the University of Toronto's Donnelly Centre for Cellular and Biomolecular Research have found two enzymes that work against the chemotherapy drug gemcitabine, preventing it from ...
- Opdivo Plus Chemotherapy Approved for First-Line Tx of Urothelial Carcinomaon March 6, 2024 at 4:00 pm
Treatment with nivolumab plus cisplatin and gemcitabine reduced the risk of death by 22% and reduced the risk for disease progression or death by 28% vs chemotherapy alone. The Food and Drug ...
- Weekly Gemcitabine and Trastuzumab in the Treatment of Patients with HER2-overexpressing Metastatic Breast Canceron February 16, 2024 at 4:00 pm
Background: The use of trastuzumab in combination with either a taxane or vinorelbine has improved the efficacy of treatment for women with HER2-positive (HER+) breast cancer. We investigated the ...
- Side Effectson January 5, 2024 at 1:45 am
Tell your doctor if you are pregnant or plan to become pregnant. You should not become pregnant while using gemcitabine. Gemcitabine may harm an unborn baby. Your doctor should order a pregnancy ...
- Gemcitabine remains the standard of care for pancreatic canceron March 30, 2023 at 5:48 pm
Pancreatic cancer is the fourth leading cause of cancer death in the US, with over 35,000 deaths reported in 2009. 1 In 1997, gemcitabine became the standard of care for advanced disease and since ...
- Side effect(s) of Decitabineon March 18, 2018 at 7:50 am
Review the side-effects of Decitabine as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of ...
The Latest Google Headlines on:
Decitabine and gemcitabine
[google_news title=”” keyword=”Decitabine and gemcitabine” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
HIV
- CRISPR Gene-Editing Emerges as a Potential Game-Changer in the Battle Against HIVon March 28, 2024 at 9:18 pm
In a groundbreaking advance, scientists have succeeded in utilizing CRISPR, the gene-editing technology that earned a Nobel Prize, to excise the HIV virus from infected cells. This innovative approach ...
- How to Tackle the HIV Epidemic Using AIon March 28, 2024 at 2:34 pm
Ramin Bastani, founder and CEO of Healthvana, based in Los Angeles, spoke about the current state of HIV in the United States and how his company is helping lower infection rates through patient ...
- Exploring the relationship between HIV pre-exposure prophylaxis and the incidence of chlamydia, gonorrhea and syphilison March 28, 2024 at 2:15 pm
In their research article published in Eurosurveillance, von Schreeb et al. challenge existing assumptions regarding the relationship between the use of HIV pre-exposure prophylaxis (PrEP) and the ...
- New Method Developed to Isolate HIV Particles, Simplifying Detectionon March 28, 2024 at 11:26 am
Researchers at Leipzig University and Ulm University have developed a new method to isolate HIV from samples more easily, potentially making it easier to detect infection with the virus. They focus on ...
- Stopping HIV in Its Tracks: New Anti-Viral Treatment Hacks the Virus’ Protective Shieldon March 27, 2024 at 9:47 pm
Just over a year ago, the European Union and the US Food and Drug Administration approved a new anti-retroviral medication aimed at combating human immunodeficiency virus (HIV) infections. Named ...
- Nashville PD to stop rejecting HIV-positive officers after settlementon March 27, 2024 at 3:33 pm
Metropolitan Nashville Police officers will no longer be disqualified on the sole basis of HIV status, the city agreed in a legal settlement Friday.
- Half of those with HIV in developed countries are at least age 50, at higher risk of frailty and multiple comorbiditieson March 27, 2024 at 3:10 pm
A new research review to be presented at a pre-congress day for this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2024) will focus on the growing prevalence of HIV ...
- HIV Cure Nearer With Way to 'Shock and Kill' Latent Viruson March 27, 2024 at 10:55 am
HIV, or human immunodeficiency virus, attacks the immune system, specifically targeting CD4 cells, which are crucial for helping the body fight infections and diseases. Without treatment, HIV can ...
- The COVID-19 pandemic has left millions disabled, including many of us with HIV—It’s time to fight for disability justiceon March 27, 2024 at 9:33 am
It doesn’t have to be this way. We call on our elected leaders to commit to continued funding of programs for the HIV community, and to creating new programs to support those with ME/CFS or long COVID ...
- HIV-Free Hopes Raised by Reservoir-Targeting VLPson March 26, 2024 at 6:00 pm
Step toward an HIV cure: a "shock and kill" virus-like particle shows promise as latency reversal agent in blood samples from chronic HIV patients.
The Latest Google Headlines on:
HIV
[google_news title=”” keyword=”HIV” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]